. Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. JAMA Neurol. 2015 Nov;72(11):1275-80. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
neurogranin
(CSF)
AD
(65)
2682 ± 1519
pg/mL §
Single Molecule Counting Immunoassay;
Erenna;
Singulex, Inc.
McKhann et al., 1984
neurogranin
(CSF)
CTRL-
Other Controls
(37)
2050 ± 1118
pg/mL §
Single Molecule Counting Immunoassay;
Erenna;
Singulex, Inc.
neurogranin
(CSF)
MCI-AD
(36)
3219 ± 2098
pg/mL §
Single Molecule Counting Immunoassay;
Erenna;
Singulex, Inc.
neurogranin
(CSF)
MCI-Stable
(17)
1792 ± 991
pg/mL §
Single Molecule Counting Immunoassay;
Erenna;
Singulex, Inc.
Petersen et al., 1999

§ Data supplied to Alzforum by author

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.